Skip to main content
. 2014 Dec 31;9(12):e115955. doi: 10.1371/journal.pone.0115955

Table 2. Association between haplotypes of PGC tagSNPs and risks of atrophic gastritis and gastric cancer.

Haplotypeb CON GA GC GA vs. CON GC vs. CON
OR(95%CI)a Pa OR(95%CI) Pa
TTCA 70(4.18%) 100(6.76%) 74(6.00%) 1.78(1.20,2.65) 0.001 1.70(1.11,2.60) 0.021
TTCG 467(27.84%) 364(24.62%) 326(26.63%) 0.86(0.72,1.03) 0.112 0.96(0.80,1.16) 0.670
TTGG 65(3.90%) 45(3.05%) 27(2.19%) 0.59(0.37,0.94) 0.023 0.54(0.31,0.94) 0.017
TCCA 166(9.88%) 155(10.47%) 126(10.27%) 1.32(1.00,1.73) 0.053 1.17(0.87,1.57) 0.277
TCCG 516(30.73%) 465(31.39%) 366(29.87%) 1.02(0.86,1.21) 0.851 0.92(0.75,1.10) 0.422
TCGA 134(8.01%) 106(7.17%) 101(8.23%) 0.83(0.62,1.12) 0.246 1.00(0.74,1.35) 0.896
CTCA 133(7.90%) 155(10.47%) 111(9.06%) 1.33(1.01,1.74) 0.041 1.19(0.88,1.61) 0.837
CTCG 105(6.24%) 74(5.03%) 71(5.78%) 0.78(0.54,1.12) 0.178 0.90(0.62,1.30) 0.216
a

, P, OR and corresponding 95%CI for individual haplotype test compares with the remaining haplotype pooled together;

b

, haplotype of Haplotype of rs6941539 C>T-rs6912200 C>T-rs3789210 C>G-rs6939861 G>A. All tests were adjusted by age, sex and status of H. pylori infection. The results highlighted in bold show associations with disease risk (P values <0.05). Abbreviation: CON: healthy controls; GA: atrophic gastritis, GC: gastric cancer.